Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.19.3.a.u2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Accounts payable, related parties $ 0 $ 125  
Accrued expenses, related parties $ 702 $ 699  
Preferred Stock, Shares Authorized 1,000,000    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001  
Common Stock, Shares Authorized 275,000,000 275,000,000  
Common Stock, Shares, Issued 54,567,455 20,152,458  
Common Stock, Shares, Outstanding 54,567,455 20,152,458  
iBio CMO [Member]      
Preferred Stock, No Par Value $ 0 $ 0  
Preferred Stock, Shares Authorized 1,000,000 1,000,000  
Preferred Stock, Shares Issued 1 1  
Preferred Stock, Shares Outstanding 1 1  
Series A Preferred Stock [Member]      
Preferred Stock, No Par Value $ 1,000   $ 1,000
Preferred Stock, Shares Authorized 6,300 6,300  
Preferred Stock, Shares Issued 12 3,987  
Preferred Stock, Shares Outstanding   3,987  
Series B Preferred Stock [Member]      
Preferred Stock, No Par Value $ 1,000 $ 1,000  
Preferred Stock, Shares Authorized 5,785 5,785  
Preferred Stock, Shares Issued 5,785 5,785  
Preferred Stock, Shares Outstanding 5,785 5,785  
Series C Preferred Stock [Member]      
Preferred Stock, No Par Value $ 1,000 $ 1,000  
Preferred Stock, Shares Authorized 4,510 4,510  
Preferred Stock, Shares Issued 20 0  
Preferred Stock, Shares Outstanding 20 0